• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Genom . Single-cell genome-wide association reveals that a nonsynonymous variant in ERAP1 confers increased susceptibility to influenza virus

tetano

Editor, Senior Moderator
Cell Genom


. 2022 Nov 9;2(11):100207.
doi: 10.1016/j.xgen.2022.100207.
Single-cell genome-wide association reveals that a nonsynonymous variant in ERAP1 confers increased susceptibility to influenza virus


Benjamin H Schott[SUP] 1 2 3 [/SUP], Liuyang Wang[SUP] 1 3 [/SUP], Xinyu Zhu[SUP] 1 [/SUP], Alfred T Harding[SUP] 1 [/SUP], Emily R Ko[SUP] 4 5 [/SUP], Jeffrey S Bourgeois[SUP] 1 2 [/SUP], Erica J Washington[SUP] 6 [/SUP], Thomas W Burke[SUP] 4 [/SUP], Jack Anderson[SUP] 4 [/SUP], Emma Bergstrom[SUP] 7 [/SUP], Zoe Gardener[SUP] 7 [/SUP], Suzanna Paterson[SUP] 7 [/SUP], Richard G Brennan[SUP] 6 [/SUP], Christopher Chiu[SUP] 7 [/SUP], Micah T McClain[SUP] 4 8 9 [/SUP], Christopher W Woods[SUP] 4 8 9 [/SUP], Simon G Gregory[SUP] 10 [/SUP], Nicholas S Heaton[SUP] 1 [/SUP], Dennis C Ko[SUP] 1 2 9 11 [/SUP]



Affiliations
Free PMC article

Abstract

During pandemics, individuals exhibit differences in risk and clinical outcomes. Here, we developed single-cell high-throughput human in vitro susceptibility testing (scHi-HOST), a method for rapidly identifying genetic variants that confer resistance and susceptibility. We applied this method to influenza A virus (IAV), the cause of four pandemics since the start of the 20[SUP]th[/SUP] century. scHi-HOST leverages single-cell RNA sequencing (scRNA-seq) to simultaneously assign genetic identity to cells in mixed infections of cell lines of European, African, and Asian origin, reveal associated genetic variants for viral burden, and identify expression quantitative trait loci. Integration of scHi-HOST with human challenge and experimental validation demonstrated that a missense variant in endoplasmic reticulum aminopeptidase 1 (ERAP1; rs27895) increased IAV burden in cells and human volunteers. rs27895 exhibits population differentiation, likely contributing to greater permissivity of cells from African populations to IAV. scHi-HOST is a broadly applicable method and resource for decoding infectious-disease genetics.
 
Back
Top Bottom